Quick Facts
Paxil Reference Guide
Injured by Paxil?
Paxil and other SSRI's may be causing birth defects.On December 13, 2006, the FDA announced antidepressants prescribed to young adults are risky. The agency proposed expanding the labels of all antidepressants to include an expanded warning of suicidal thoughts in patients ranging from 18-24 years of age. The newly presented change would expand a warning now on the labels that pertain only to children and adolescents treated with antidepressant drugs. The new label changes would also contain a suggestion that patients of all ages be carefully monitored, particularly when starting antidepressant treatment.
The FDA recently completed a bulk evaluation of 372 studies involving approximately 100,000 patients and 11 antidepressants, including Lexapro, Zoloft, Prozac and Paxil. When the results are analyzed by age, it becomes clear there is an elevated risk for suicidal thoughts and behavior among adults 18 to 25 that approaches that seen in children, the FDA said in documents released before their scheduled December 13, 2006 meeting of its psychopharmacologic drugs advisory committee.
In May 2006, GlaxoSmithKline and the FDA cautioned Paxil may raise the risk of suicidal behavior in young adults too and changed the drug’s label to reflect that risk.
New Paxil Suicide Warning
Paxil (Generic: Paroxetine hci) has been linked with suicide, suicidal ideation and violence in children and teenagers. On May 12, 2006, the FDA issued a Paxil warning when results of a study became public showing that Paxil also increases suicide risk in young adults aged 18-30. An analysis of multiple trials including 15,000 patients revealed 11 attempted suicides among Paxil users and only 1 attempted suicide among those taking the pacebo. Of the 11 suicide attempts in Paxil users, 8 were in people aged 18 to 30. Paxil is most commonly used to treat depression but is also prescribed to treat anxiety, panic, obsessive compulsive disorder, and post traumatic stress disorder. An estimated 17 million people worldwide have been treated with Paxil.
In September 2004, the FDA issued a warning for Paxil, stating that the drug can cause suicide and violence in children and teenagers. This follows a report issued by Britain's Department of Health which said that evidence provided by the drug company from nine studies based on more than 1,000 youngsters shows there is an increase in the rate of self harm and potentially suicidal behavior in those under 18 taking Paxil. British health regulators recently issued a warning and stated: "It has become clear that the benefits of Seroxat in children for the treatment of depressive illness do not outweigh these risks." Following their British counterparts, Irish health officials issued a warning for Paxil in Ireland, and the FDA continues to investigate the suicide risk associated with Paxil and other antidepressants.
Birth Defects
The FDA is strengthening its warning for the antidepressant Paxil because it may be associated with birth defects, citing a new study that found increased risk of fetuses developing heart defects. The FDA asked manufacturer GlaxoSmithKline to reclassify the drug, which goes by the generic name Paroxetine, as a "Category D" drug for pregnant women. The classification means that studies in pregnant women have shown a risk to the fetus. Two studies of pregnant women taking Paxil during their first trimester showed that their babies have heart defects at a rate of 1.5 to 2 times the norm. The FDA is advising doctors not to prescribe Paxil to women in their first three months of pregnancy or people who are planning to become pregnant, unless there are no other options.
Withdrawal Symptoms
Paxil has long been associated with difficult withdrawal side effects, leaving patients virtually addicted to the drug. Recently, The British drug agency required Glaxo to remove a statement on its patient label saying that the drug was not addictive. Paxil has been associated with difficult withdrawal side-effects. Often these withdrawal effects are experienced just hours after a missed dose. Paxil withdrawal symptoms include a "flu-like" syndrome, anxiety, dizziness, fatigue, headache, migraine-like feelings, nerves jangling when moving eyes, continuous indigestion, neck and back pain, psychotic features such as visual and/or audio hallucinations/illusions, insomnia, nausea, restlessness, "electrical shock" phenomena/electrical surges or shocks through the head and/or body, hyper-sensitivity of the nervous system to light, sound, colors & stressors, tremors, tinnitus and a vertiginous-like experience, depressive thoughts, suicidal thoughts, homicidal thoughts, extreme anger, severe agitation, extreme irritability, "over-reacting", ringing in ears and throbbing in head, vomiting, paranoia, aggressive behavior, roller-coaster emotions, out of character behavior, severe malaise, general dysphoria, derealization and panic attacks.
In addition to the aforementioned side effects associated with antidepressants, a new study has linked these drugs to an increased risk of death amongst patients with coronary artery disease. This study, which was conducted at Duke University, analyzed the survival rate of heart disease patients using antidepressants compared with those not using these drugs.
During an average of three years of follow-up, 21.4% of the patients taking antidepressants died compared with 12.5% of those not on antidepressants. After adjusting for demographic factors, cardiac risk factors, scores on the Beck Depression Inventory test, and the presence of other illness, antidepressant use was an independent risk factor for mortality, increasing the risk by 62%.
Researchers do not fully understand why antidepressants increase the risk of mortality in these patients. However their findings are statistically significant and show that these drugs do increase the risk of death in heart disease patients. Current and former heart disease patients should weigh the risks and benefits of antidepressants before using these medications.
If you or a loved one took Paxil and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney.
PaxilRSS Feed
Glaxo Paxil Birth Defects Settlements Total $1 Billion
Jul 22, 2010 | Parker Waichman Alonso LLP
GlaxoSmithKline (GSK) has agreed to pay in excess of $1 billion to settle hundreds of lawsuits over claims of birth defects linked to Paxil, said Fierce Pharma. The $1 billion is from the drug maker’s $2.4 billion legal expense budget and will pay about $1.2 million to each of families whose children were born with birth defects following their mothers’ use of Paxil during pregnancy, said Fierce Pharma. Over 800 birth defect cases will be resolved with this massive settlement; over...
Another Paxil Birth Defect Lawsuit Reported Settled
Jul 20, 2010 | Parker Waichman Alonso LLP
GlaxoSmithKline may have settled another Paxil birth defect lawsuit. According to the Associated Press, the lawsuit was filed by a South Dakota woman who blamed the antidepressant for the death of her infant son. The suit was brought by Jennifer Berg in 2007, who took Paxil while she was pregnant. She claimed that her use of Paxil caused her son, Nathan, to be born with Persistent Pulmonary Hypertension of the Newborn (PPHN), a heart disorder which prevents proper oxygenation of the blood....
Paxil, Zoloft, LexaPro and Others Linked To Birth Defects
May 21, 2010 | Parker Waichman Alonso LLP
If you are pregnant and taking an antidepressant, you need to talk with your doctor. Some popular antidepressants have been linked to an increased risk of birth defects. Just this month, a study published in the American Journal of Obstetrics & Gynecology had found that bupropion – sold as an antidepressant under the name Wellbutrin and as a stop-smoking aid under the name Zyban – was also associated with an increased risk of cardiac birth defects. The study examined...
No Preemption in Paxil Suicide Case
Mar 2, 2010 | Parker Waichman Alonso LLP
A lawsuit filed by the family of a young woman who committed suicide after taking Paxil will go forward, after an appeals court ruled that it is not preempted.Paxil is one of a class of drugs called selective serotonin reuptake inhibitors (SSRIs), and has been approved to treat symptoms of depression, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), panic disorder, generalized anxiety disorder (GAD), social phobia/social anxiety disorder, and premenstrual dysphoric...
Mildly Depressed Patients Not Helped Much by Antidepressants
Jan 6, 2010 | Parker Waichman Alonso LLP
The wisdom of treating mildly depressed people with antidepressants like Paxil is being questioned by a new study published in the Journal of the American Medical Association (JAMA). In the U.S., antidepressants are used by nearly 15 million adults every year. Many of these patients fall into the mild or moderately depressed category, yet few studies have been conducted on the effectiveness of antidepressants on such patients. Most studies - including those used to assess a...

